These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27036872)

  • 1. Hepatocyte growth factor as a downstream mediator of vascular endothelial growth factor-dependent preservation of growth in the developing lung.
    Seedorf G; Metoxen AJ; Rock R; Markham N; Ryan S; Vu T; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1098-110. PubMed ID: 27036872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia.
    Kunig AM; Balasubramaniam V; Markham NE; Seedorf G; Gien J; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L1068-78. PubMed ID: 16829629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamic changes in vascular endothelial growth factor and endothelial nitric oxide synthase in lungs of premature rats after hyperoxia exposure].
    Wei W; Wang W; Ning Q; Luo XP
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):473-8. PubMed ID: 17937862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor.
    Tang JR; Markham NE; Lin YJ; McMurtry IF; Maxey A; Kinsella JP; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2004 Aug; 287(2):L344-51. PubMed ID: 15064225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor stimulates nitric oxide production through endothelial nitric oxide synthase activation by the phosphoinositide 3-kinase/Akt pathway and possibly by mitogen-activated protein kinase kinase in vascular endothelial cells.
    Uruno A; Sugawara A; Kanatsuka H; Arima S; Taniyama Y; Kudo M; Takeuchi K; Ito S
    Hypertens Res; 2004 Nov; 27(11):887-95. PubMed ID: 15824471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep.
    Rozance PJ; Seedorf GJ; Brown A; Roe G; O'Meara MC; Gien J; Tang JR; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L860-71. PubMed ID: 21873446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rhVEGF treatment preserves pulmonary vascular reactivity and structure in an experimental model of pulmonary hypertension in fetal sheep.
    Grover TR; Parker TA; Markham NE; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2005 Aug; 289(2):L315-21. PubMed ID: 15833763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperoxia disrupts vascular endothelial growth factor-nitric oxide signaling and decreases growth of endothelial colony-forming cells from preterm infants.
    Fujinaga H; Baker CD; Ryan SL; Markham NE; Seedorf GJ; Balasubramaniam V; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1160-9. PubMed ID: 19734318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of EC-SOD worsens alveolar and vascular development in a neonatal mouse model of bleomycin-induced bronchopulmonary dysplasia and pulmonary hypertension.
    Delaney C; Wright RH; Tang JR; Woods C; Villegas L; Sherlock L; Savani RC; Abman SH; Nozik-Grayck E
    Pediatr Res; 2015 Dec; 78(6):634-40. PubMed ID: 26322414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse.
    Balasubramaniam V; Tang JR; Maxey A; Plopper CG; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2003 Jun; 284(6):L964-71. PubMed ID: 12588707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early inhaled nitric oxide treatment decreases apoptosis of endothelial cells in neonatal rat lungs after vascular endothelial growth factor inhibition.
    Tang JR; Seedorf G; Balasubramaniam V; Maxey A; Markham N; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1271-80. PubMed ID: 17827251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism of MSC-secreted HGF and VEGF in stabilising endothelial barrier function upon lipopolysaccharide stimulation via the Rac1 pathway.
    Yang Y; Chen QH; Liu AR; Xu XP; Han JB; Qiu HB
    Stem Cell Res Ther; 2015 Dec; 6():250. PubMed ID: 26674641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signaling.
    Gien J; Seedorf GJ; Balasubramaniam V; Markham N; Abman SH
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1146-53. PubMed ID: 17823355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.
    Wojta J; Kaun C; Breuss JM; Koshelnick Y; Beckmann R; Hattey E; Mildner M; Weninger W; Nakamura T; Tschachler E; Binder BR
    Lab Invest; 1999 Apr; 79(4):427-38. PubMed ID: 10211995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway.
    Min JK; Lee YM; Kim JH; Kim YM; Kim SW; Lee SY; Gho YS; Oh GT; Kwon YG
    Circ Res; 2005 Feb; 96(3):300-7. PubMed ID: 15637298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Nitric Oxide Isoforms in Vascular and Alveolar Development and Lung Injury in Vascular Endothelial Growth Factor Overexpressing Neonatal Mice Lungs.
    Syed MA; Choo-Wing R; Homer RJ; Bhandari V
    PLoS One; 2016; 11(1):e0147588. PubMed ID: 26799210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase.
    Stahmann N; Woods A; Spengler K; Heslegrave A; Bauer R; Krause S; Viollet B; Carling D; Heller R
    J Biol Chem; 2010 Apr; 285(14):10638-52. PubMed ID: 20129920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells.
    Yo Y; Morishita R; Nakamura S; Tomita N; Yamamoto K; Moriguchi A; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Kidney Int; 1998 Oct; 54(4):1128-38. PubMed ID: 9767528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF.
    Endo A; Fukuhara S; Masuda M; Ohmori T; Mochizuki N
    J Recept Signal Transduct Res; 2003; 23(2-3):239-54. PubMed ID: 14626450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.